Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography.

Because of its cost effectiveness, wide availability, and technical ease of application, ultrasonography is the reference method for determining the thyroid volume prior to radioiodine therapy. The goal of the study is a prospective assessment of the deviation between volumetric ultrasonography measurements in comparison to those performed with three-dimensional magnetic resonance imaging (MRI). To that end, 60 consecutive patients with multinodular toxic goiter (n = 28, 46.7%) or Graves' disease (n = 32, 53.3%) were included in the study. Ultrasonographic volumetry according to the well-known ellipsoid formula was performed by three different technicians. In addition, three-dimensional MRI scans of the neck area were acquired and evaluated by the ellipsoid formula as well as by a dedicated region-of-interest technique (MRI-ROI), which was used as standard of reference. While there was no significant difference between the ultrasonographic examinations of the three technicians, a highly significant mean deviation of 22.7% (10.4 mL) was found between the sonographic measurements and the MRI-ROI results (p < 0.01) that were underestimated in 80% of the cases. Correlation coefficients between the various volumetric approaches were highly significant, with values of at least 0.886 (p < 0.01). An additional analysis of volume-dependent subgroups revealed that thyroid volume had no significant influence on the results of ultrasonographic volumetry (p > 0.15). In conclusion, the study showed ultrasonography to be a reliable method of satisfactory accuracy that is appropriate for volumetric thyroid measurements. The findings indicate that the use of a correction factor higher than 0.52 in the ellipsoid formula is recommended to improve accuracy. However, further studies are necessary to confirm these findings.

Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).

The aim of this study was to explore the sites of metabolic changes with [(18)F]2-fluoro-2-desoxy-D-glucose (FDG) and positron emission tomography (PET) in patients with Creutzfeldt-Jakob disease and to correlate the findings with clinical symptoms. Static [(18)F]FDG-PET studies of eight patients with the diagnosis of confirmed or probable CJD were retrospectively analysed by two physicians from departments of nuclear medicine independently with a strong interrater agreement (kappa=0,98). The clinical data of the patients, based on a standardized evaluation by physicians from the German Creutzfeldt-Jakob disease surveillance study, was correlated with the PET findings. [(18)F]FDG-PET shows widespread hypometabolism in CJD. All patients had a reduction of cerebral glucose metabolism in at least one temporal or parietal region. Additionally in 7 of our own 8 cases and 3 of 4 cases from the literature the occipital lobe, the cerebellum or the basal ganglia were involved. These findings differ from typical patterns of hypometabolism in Alzheimer's disease and other neurodegenerative disorders. In two thirds of the cases the distribution was markedly asymmetric. Myoclonus was present in five out of our eight own cases. Our data suggest that myoclonus might correlate with metabolic impairment of contralateral parietal and temporal lobes. In three of four patients with visual symptoms FDG uptake was reduced in the visual cortex bilaterally. Typical hyperintensities on MRI were only found in two of the eight cases at the time of PET-studies. Our results demonstrate that [(18)F]FDG-PET appears to be a sensitive investigation in CJD and could be useful to differentiate CJD from other neurodegenerative disorders.

Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function.

OBJECTIVES: This study sought to evaluate whether objective assessment of the myocardial functional reserve, using strain rate imaging (SRI), allows accurate detection of viable myocardium. BACKGROUND: Strain rate imaging is a new echocardiographic modality that allows quantitative assessment of segmental myocardial contractility. METHODS: In 37 patients (age 58 +/- 9 years) with ischemic left ventricular dysfunction, myocardial viability was assessed using low-dose (10 microg/kg body weight per min) two-dimensional dobutamine stress echocardiography (DSE), tissue Doppler imaging, SRI and (18)F-fluorodeoxyglucose ((18)FDG) positron emission tomography (PET). The peak systolic tissue Doppler velocity and peak systolic myocardial strain rate were determined at baseline and during low-dose dobutamine stress from the apical views. RESULTS: A total of 192 segments with dyssynergy at rest were classified by (18)FDG PET as viable in 94 and nonviable in 98. An increase of peak systolic strain rate from rest to dobutamine stimulation by more than -0.23 1/s allowed accurate discrimination of viable from nonviable myocardium, as determined by (18)FDG PET with a sensitivity of 83% and a specificity of 84%. Receiver operating characteristic (ROC) curve analysis showed an area under the curve for prediction of nonviable myocardium, as determined by (18)FDG PET using SRI, of 0.89 (95% confidence interval [CI] 0.88 to 0.90), whereas the area under the ROC curve using tissue Doppler imaging was 0.63 (95% CI 0.61 to 0.65). CONCLUSIONS: The increase in the peak systolic strain rate during low-dose dobutamine stimulation allows accurate discrimination between different myocardial viability states. Strain rate imaging is superior to two-dimensional DSE and tissue Doppler imaging for the assessment of myocardial viability.

Quantitative Stress Echocardiography in Chronic Aortic and Mitral Regurgitation.

It was the purpose of the present study to prove the feasibility and reliability of quantitative stress-echocardiography as an alternative method to radionuclide angiography (RNA) in chronic regurgitant valvular lesions. Echocardiography and RNA are most commonly used to obtain various left ventricular (LV) morphometric and functional parameters that have been postulated to predict long-term prognosis in patients with aortic and mitral valvular regurgitation. Supine bicycle ergometry with a workload ranging from 25-250 Watts was used to evaluate stress dependent LV volumes and ejection fractions (EFs) in patients with pure aortic (n = 18) and mitral regurgitation (n = 14). Most patients (23/32) underwent simultaneous right heart catheterization. Echocardiographic EFs were validated by RNA with good correlations (r = 0.81, P < 0.01). Patients with aortic regurgitation and functional class I/II (9), had a significant increase in EF during exercise (60%-67%, P < 0.001) and a reduction in end-systolic volume (71-52 mL, P < 0.01). In comparison, patients with class III symptoms (9), had a drop in EF (53%-49%, P < 0.01), had larger baseline end-systolic volume (104 mL, P = NS), which did not decrease during stress (104 vs 107 mL, P = NS). In patients with chronic mitral regurgitation baseline and exercise EF did not differ between class I/II (6) and class III (8), however, mildly symptomatic patients increased from 57%-67%, (P < 0.01) versus patients in class III (65% vs 69%, P = NS). Stroke volume index was not different at baseline (44 vs 33 mL/m(2), P = NS); however, there were significant differences during exercise (70 vs 41 mL/m(2), P = 0.05). Quantitative stress-echocardiography is a noninvasive and safe alternative method to RNA, which allows reliable calculation of stress dependent LV volumes and EF. Determination of end-systolic volumes may be of additional prognostic value. The combination of a high baseline EF and low stroke volume index with the inability to improve during exercise might reflect early stages of impaired LV function in patients with severe mitral regurgitation.